🔎 Trials Near Me

Home › NCT03849963

Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain

RecruitingObservational studyHealthy volunteers welcome

Who can join

Ages 18 to 60 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* 18 through 60 years of age.
* Healthy, with no neurological abnormalities.
* Ability to understand and the willingness to sign a written informed consent.
* All races and ethnicities will be included; subjects must be able to read and speak the English language.

Exclusion Criteria:

* Metallic foreign bodies on the scalp or cranium which may interfere with MRI acquisitions
* Major debilitating neurological disease including, but not limited to, stroke, CVA, dementia and tumor that would limit compliance with study requirements
* Under influence of illicit drugs which are known to alter brain physiology/metabolism including, but not limited to cocaine, lysergic acid diethylamide (LSD), and marijuana at the time of MRI/MRSI scanning.
* Under influence of antiepileptic drugs at the time of MRI/MRSI scanning.
* Any contraindication per MRI Screening Form including
* Implants contraindicated at 3T, pacemakers
* Implantable Cardioverter Defibrillator (ICD)
* Claustrophobia
* Medically unstable including
* Heart failure
* Severe left ventricular outflow tract (LVOT) obstruction
* Unstable angina
* Pregnancy
* Lactating

About the study

Investigators propose to develop hyperpolarized \[13C\]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism and synthesis of a neurotransmitter in this observational study.

Sponsor: University of Texas Southwestern Medical Center · Participants: 28 · Started: Jul 30, 2030

Contact the study team

Official record on ClinicalTrials.gov — NCT03849963

Locations in the U.S.

TexasUT Southwestern - Advanced Imaging Research Center, Dallas

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.